A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease.

Gastrointest Endosc

Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA; Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

Published: April 2014

Background: Phenotypes of eosinophilic esophagitis (EoE) are not well-characterized.

Objective: To describe clinical features of patients with EoE with predefined phenotypes, determine predictors of these phenotypes, and make inferences about the natural history of EoE.

Design: Retrospective study.

Setting: Tertiary-care center.

Patients: Incident EoE cases from 2001 to 2011 that met consensus diagnostic guidelines.

Intervention: Review of records.

Main Outcome Measurements: Endoscopic phenotypes, including fibrostenotic, inflammatory, or mixed. Other groups of clinical characteristics examined included atopy, level of esophageal eosinophilia, and age of symptom onset. Multinomial logistic regression assessed predictors of phenotype status.

Results: Of 379 cases of EoE identified, there were no significant phenotypic differences by atopic status or level of eosinophilia. Those with the inflammatory phenotype were more likely to be younger than those with mixed or fibrostenotic (13 vs 29 vs 39 years, respectively; P < .001) and less likely to have dysphagia, food impaction, and esophageal dilation (P < .001 for all). The mean symptom length before diagnosis was shorter for inflammatory (5 vs 8 vs 8 years; P = .02). After multivariate analysis, age and dysphagia independently predicted phenotype. The odds ratio (OR) for fibrostenosis for each 10-year increase in age was 2.1 (95% CI, 1.7-2.7). The OR for dysphagia was 7.0 (95% CI, 2.6-18.6).

Limitations: Retrospective, single-center study.

Conclusion: In this large EoE cohort, the likelihood of fibrostenotic disease increased markedly with age. For every 10-year increase in age, the odds of having a fibrostenotic EoE phenotype more than doubled. This association suggests that the natural history of EoE is a progression from an inflammatory to a fibrostenotic disease.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599711PMC
http://dx.doi.org/10.1016/j.gie.2013.10.027DOI Listing

Publication Analysis

Top Keywords

fibrostenotic disease
12
eosinophilic esophagitis
8
natural history
8
10-year increase
8
increase age
8
eoe
7
fibrostenotic
6
age
5
phenotypic analysis
4
analysis eosinophilic
4

Similar Publications

ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis.

Am J Gastroenterol

January 2025

Kennth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Article Synopsis
  • Eosinophilic esophagitis (EoE) is a chronic immune disease characterized by symptoms of esophageal dysfunction and an eosinophil-dominated infiltration in the esophagus.
  • The incidence of EoE is rising, requiring attention in various medical settings, leading to updated guidelines that focus on improved diagnosis and treatment strategies.
  • Recommended treatments include proton pump inhibitors, topical steroids, dietary elimination, and esophageal dilation, with an emphasis on monitoring patients for treatment response and managing both inflammatory and structural aspects of the disease.
View Article and Find Full Text PDF

Fibrosis is the pathological consequence of chronic inflammation. In Crohn's disease (CD), fibrostenotic complications occur with 50-70 % frequency as a failure to properly repair the tissue damage. Intestinal stenosis requires surgical intervention and relapses in most patients.

View Article and Find Full Text PDF

Development and Validation of the PICK-UP-STRICS Score to Predict Fibrostenosis in Patients with EoE Prior to Endoscopy.

Dig Dis Sci

December 2024

Division of Gastroenterology & Hepatology, Department of Medicine, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

Background: Predicting fibrostenotic complications prior to endoscopy in eosinophilic esophagitis (EoE) is challenging and esophageal strictures and narrowing are commonly missed on endoscopy.

Aim: To develop and validate a score to predict fibrostenosis in EoE patients prior to endoscopy.

Methods: We leveraged a large database of newly diagnosed EoE patients.

View Article and Find Full Text PDF
Article Synopsis
  • * A 28-year-old man with worsening EoE symptoms, treated with fluticasone via inhaler for seven years, developed limping and groin pain leading to hip replacements after MRI confirmed bilateral AVN.
  • * After stopping the inhaled steroid and starting dupilumab treatment, the patient’s EoE symptoms improved significantly, highlighting the importance of recognizing potential serious side effects of topical corticosteroids among healthcare professionals.
View Article and Find Full Text PDF
Article Synopsis
  • * Conducted on 65 CD patients, the findings showed that 32 exhibited the bright luminal sign, which demonstrated high sensitivity (90%) and specificity (85%) in identifying fibrotic strictures when compared with other imaging techniques.
  • * The results suggest that DWI hyperintensity could serve as a non-invasive indicator for detecting severe intestinal fibrosis, aiding in early diagnosis and potentially preventing complications. However, further research with larger
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!